Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Change in Accured Expenses (2016 - 2025)

Healthstream (HSTM) has disclosed Change in Accured Expenses for 16 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 97.76% to $6.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 128.27% increase, with the full-year FY2025 number at $1.4 million, up 128.27% from a year prior.
  • Change in Accured Expenses was $6.6 million for Q4 2025 at Healthstream, up from -$1.3 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $6.6 million in Q4 2025 to a low of -$7.4 million in Q1 2024.
  • A 5-year average of $31600.0 and a median of $775000.0 in 2022 define the central range for Change in Accured Expenses.
  • Biggest YoY gain for Change in Accured Expenses was 329.81% in 2025; the steepest drop was 346.58% in 2025.
  • Healthstream's Change in Accured Expenses stood at -$1.3 million in 2021, then skyrocketed by 320.99% to $2.8 million in 2022, then soared by 98.61% to $5.6 million in 2023, then tumbled by 39.87% to $3.3 million in 2024, then surged by 97.76% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Change in Accured Expenses are $6.6 million (Q4 2025), -$1.3 million (Q3 2025), and $3.4 million (Q2 2025).